A review of the indications, safety, and efficacy of deucravacitinib: An expert consensus panel.

Shah M, DeBusk L, Bohman MH, Rosenberg A, Burshtein J, Zakria D, Armstrong A, Boh E, Gottlieb AB, Khattri S, Litchman G, Merola J, Murina A, Lebwohl M

Open source

DOI: 10.25251/ymnfwz12
Published: 2026 May 8
Container: Dermatology online journal
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.25251/ymnfwz12,
  title = {A review of the indications, safety, and efficacy of deucravacitinib: An expert consensus panel.},
  author = {Shah M and DeBusk L and Bohman MH and Rosenberg A and Burshtein J and Zakria D and Armstrong A and Boh E and Gottlieb AB and Khattri S and Litchman G and Merola J and Murina A and Lebwohl M},
  year = {2026},
  journal = {Dermatology online journal},
  doi = {10.25251/ymnfwz12},
  url = {https://doi.org/10.25251/ymnfwz12}
}

RIS

TY  - JOUR
TI  - A review of the indications, safety, and efficacy of deucravacitinib: An expert consensus panel.
AU  - Shah M
AU  - DeBusk L
AU  - Bohman MH
AU  - Rosenberg A
AU  - Burshtein J
AU  - Zakria D
AU  - Armstrong A
AU  - Boh E
AU  - Gottlieb AB
AU  - Khattri S
AU  - Litchman G
AU  - Merola J
AU  - Murina A
AU  - Lebwohl M
PY  - 2026
JO  - Dermatology online journal
DO  - 10.25251/ymnfwz12
UR  - https://doi.org/10.25251/ymnfwz12
ER  -

APA

M, S., L, D., MH, B., A, R., J, B., D, Z., A, A., E, B., AB, G., S, K., G, L., J, M., A, M., & M, L. (2026). A review of the indications, safety, and efficacy of deucravacitinib: An expert consensus panel.. Dermatology online journal. https://doi.org/10.25251/ymnfwz12

Source records

pubmed · retrieved 2026-09-27T11:00:51.493Z